Occam Places Juan Estupinan as CFO at Vestaron
On the heels of an $82M series C fundraise, Vestaron, a leader in peptide-based biological crop protection, backed by Cavallo Ventures, Novo Holdings, Northpond Ventures, and more, has expanded its leadership team with the appointment of Juan Estupiñan as CFO. Juan will have global responsibility for corporate finance, FP&A, corporate tax, investor relations, and corporate communications.
In his prior role, Juan served as Vice President, Finance and Accounting, and Controller at neurotherapeutics biotech Aptinyx, playing a key role in the series A and B private financing rounds, the Initial Public Offering, and two subsequent funding rounds. Juan received his Bachelor of Science in Accounting and Finance from Indiana University and Master of Business Administration from Northwestern University, Kellogg School of Management.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.